Xilio Therapeutics
XLO
#9717
Rank
S$47.31 M
Marketcap
$0.91
Share price
0.31%
Change (1 day)
-53.90%
Change (1 year)

Xilio Therapeutics (XLO) - P/B ratio

P/B ratio as of April 2025 : 1.94

According to Xilio Therapeutics's latest financial reports the company has a price-to-book ratio of 5.38711.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Xilio Therapeutics - P/B ratio (from 2021 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-312.53775.73%
2023-12-310.2884-58.77%
2022-12-310.6995-70.49%
2021-12-312.37
2020-12-31N/A